Is a complete PMVP research report available?

No complete published report is available for PMV Pharmaceuticals, Inc. (PMVP) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

PMV Pharmaceuticals, Inc. (PMVP)

NASDAQ: PMVP · USD

$1.13

+0.06 (+5.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PMVP analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	60.3M
Net income (ttm)	-78.3M
EPS (ttm)	-$1.48
Shares out	53.3M
Volume	483,872
Beta	1.33
Price target	$4.00	+254.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -78.3M
EPS (ttm): -$1.48
Market cap: 60.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PMVP indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001699382
Company name	PMV Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	69353Y103
Employees	54
Employees Change	7%
Employees Change Percent	14.89
Enterprise value	$-36.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-09-25
Isin	US69353Y1038
Last refreshed	2026-07-31
Market cap	$60.3M
Market cap category	Micro-Cap
Price	$1.13
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	PMVP
Website	https://www.pmvpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-137.93%
FCF yield	-132.07%
P/B ratio	0.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-78.3M
Net Income Growth Years	0%
Profit Per Employee	$-1.5M
ROA	-39.14
Roa5y	-20.57
ROCE	-95.11
ROE	-63.16
Roe5y	-31.52
ROIC	-41.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-21.54%
Cagr3y	-44.88%
Cagr5y	-49.63%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$96.6M
Cash	$93.5M
Current Assets	$95.8M
Current Liabilities	$8.6M
Debt	$293,000
Debt Equity	$0
Equity	$88M
Liabilities	$8.6M
Long Term Assets	$782,000
Long Term Liabilities	$0
Net Cash	$93.3M
Net Cash By Market Cap	$164
Net Cash Growth	-43.38%
Net Debt Equity	$-1.06
Tangible Book Value	$88M
Tangible Book Value Per Share	$1.65
WACC	11.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.14
Net Working Capital	$-6.1M
Quick ratio	10.88
Working Capital	$87.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.28%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-21.53%
200-day SMA	1.29
3Y total return	-83.26%
50-day SMA	1.21
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.76%
All Time High	63.22
All Time High Change	-98.21%
All Time High Date	2021-01-04
All Time Low	0.81
All Time Low Change	39.51%
All Time Low Date	2025-05-13
ATR	0.08
Beta	1.33
Beta1y	0.44
Beta2y	0.5
Ch YTD	-9.6
High	1.14
High52	1.88
High52 Date	2026-03-02
High52ch	-39.89%
Low	1.05
Low52	1.02
Low52 Date	2026-02-23
Low52ch	10.78%
Ma50ch	-6.61%
Price vs 200-day SMA	-12.4%
RSI	41.72
RSI Monthly	37.18
RSI Weekly	43.22
Sharpe ratio	-0.05x
Sortino ratio	0.01
Total Return	-2.28%
Tr YTD	-9.6
Tr1m	-12.4%
Tr1w	-15.04%
Tr3m	-18.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	2
Analyst Price Target Top	$5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.4
Operating Income	$-83.7M
Price target	$4
Price Target Change	$254
Price Target Change Top	$342

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,212,446%
Float Percent	86.65%
Shares Insiders	3.37%
Shares Institutions	57.91%
Shares Out	53,331,766
Shares Qo Q	0.25%
Shares Yo Y	2.28%
Short Float	5.24%
Short Ratio	6.69
Short Shares	4.54

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-80.8M
Adjusted OCF	-80,798,000
Average Volume	312,290.2x
Bv Per Share	1.65
CAPEX	$-25,000
Ch1m	-12.4
Ch1w	-15.04
Ch1y	-21.53
Ch3m	-18.71
Ch3y	-83.26
Ch5y	-96.76
Ch6m	0.89
Change	5.61%
Change From Open	6.6
Close	1.07
Days Gap	-0.93
Depreciation Amortization	130,000
Dollar Volume	546,775.4
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-83.7M
EBITDA	$-83.5M
EPS	$-1.48
F Score	1
FCF	$-75M
FCF EV Yield	205.76x
FCF Per Share	$-1.41
Financing CF	495,000
Fiscal Year End	December
Founded	2,013
Income Tax	$25,000
Investing CF	62,282,000
Ipr	-94.08
Iprfo	-96.96
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-06
Ma150	1.27
Ma150ch	-11.16%
Ma20	1.26
Ma20ch	-9.96%
Net CF	-12,211,000
Next Earnings Date	2026-08-10
Open	1.06
Optionable	Yes
Position In Range	88.89
Ppne	486,000
Price Date	2026-07-30
Ptbv Ratio	0.65
Relative Volume	1.55x
Share Based Comp	5,808,000
Tr6m	0.89%
Us State	New Jersey
Volume	483,872

PMV Pharmaceuticals, Inc. (PMVP)

Coverage state: Market snapshot only — no published research

Generate the first PMVP analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PMVP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PMVP indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PMVP

Frequently asked questions